Research Analysts Offer Predictions for MBRX FY2025 Earnings
Moleculin Biotech, Inc. (NASDAQ:MBRX – Free Report) – Analysts at HC Wainwright boosted their FY2025 EPS estimates for Moleculin Biotech in a report released on Monday, March 24th. HC Wainwright analyst V. Bernardino now expects that the company will post earnings of ($1.65) per share for the year, up from their previous estimate of ($3.31). […]
